Today in FirstWord: Merck & Co., Zetia, Vytorin, Mylan, Sanofi, diabetes, Amgen

Today in FirstWord: Merck &amp; Co., Zetia, Vytorin, Mylan, Sanofi, diabetes, Amgen

FirstWord Pharmaceutical News for Monday, April 30, 2012

Published daily, FirstWord is a personalisable business intelligence resource for the busy pharmaceutical professional.  For more information on this time-saving tool, please visit www.firstwordpharma.com.

Business

Medicine

Business News

Published daily, FirstWord is a personalisable business intelligence resource for the busy pharmaceutical professional. For more information on this time-saving tool, please visit www.firstwordpharma.com.

Share FirstWord Pharmaceutical News for Monday, April 30, 2012

Sign up to save your podcasts

FirstWord Pharmaceutical News for Monday, April 30, 2012

FirstWord Pharmaceutical News for Monday, April 30, 2012